NCT04228991 2025-11-18
RHEAL
Ontario Clinical Oncology Group (OCOG)
Phase 3 Active not recruiting
Clinical Trials
9 trialsNCT06144164 2025-11-10
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 3 Recruiting
NCT03764943 2022-03-29
Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction
University of Wisconsin, Madison
Phase 3 Completed
NCT00577317 2021-06-23
Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer
GOG Foundation
Phase 3 Terminated
NCT00376597 2019-02-07
Education With or Without Exercise and Counseling in Preventing Lymphedema in Women With Stage I, Stage II, or Stage III Breast Cancer Who Are Undergoing Axillary Lymph Node Dissection
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT01849224 2013-07-16
Randomized Trial of Exercise on Lower Extremity Edema After Lymphadenectomy in Gynecologic Cancer
National Cancer Center, Korea
Phase 3 Unknown
NCT00028951 2013-07-09
Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the Vulva
GOG Foundation
Phase 3 Completed
NCT00287196 2013-06-25
Immediate Radiotherapy or Observation After Surgery for Melanoma Involving Lymph Nodes
Trans Tasman Radiation Oncology Group
Phase 3 Completed
NCT00201890 2012-10-10
Trial of Decongestive Lymphatic Therapy for Lymphedema in Women With Breast Cancer "DELTA STUDY"
Ontario Clinical Oncology Group (OCOG)
Phase 3 Completed